Eliquis (apixaban) is one of the most widely prescribed blood thinners in the world, and its safety profile is well established. In the landmark ARISTOTLE trial involving over 18,000 patients with atrial fibrillation, Eliquis caused 31% less major bleeding than warfarin, the older blood thinner it was designed to replace. It also reduced the risk of bleeding inside the brain by 58%. For most people, Eliquis is considered a safe and effective anticoagulant, though like all blood thinners, it carries real risks that depend on your age, kidney function, weight, and what other medications you take.
How Eliquis Works
Eliquis blocks a single protein in the clotting cascade called factor Xa. This protein is a key step in how your body forms blood clots. By selectively targeting just this one factor, Eliquis thins the blood without broadly disrupting other clotting processes. It doesn’t affect how platelets clump together, which is one reason its bleeding profile is more favorable than older anticoagulants. The drug is taken as a pill, typically twice a day, and reaches steady levels in the bloodstream without requiring the routine blood monitoring that warfarin demands.
What Eliquis Is Prescribed For
The FDA originally approved Eliquis to reduce the risk of stroke and dangerous blood clots in people with nonvalvular atrial fibrillation, a common heart rhythm disorder. It’s also used to treat and prevent deep vein thrombosis and pulmonary embolism, and to reduce clotting risk after hip or knee replacement surgery.
Eliquis has not been studied in people with mechanical (prosthetic) heart valves, and it’s not recommended for that group. It’s also completely off-limits for anyone with active internal bleeding or a known severe allergic reaction to the drug.
Bleeding Risk Compared to Warfarin
The biggest safety concern with any blood thinner is bleeding, and this is where Eliquis distinguishes itself. In the ARISTOTLE trial, major bleeding occurred at an annual rate of 2.13% with Eliquis compared to 3.09% with warfarin. That difference was statistically significant. Intracranial hemorrhage, the most feared complication of blood thinners, was reduced by 58% with Eliquis compared to warfarin.
These numbers don’t mean Eliquis is risk-free. A 2% annual rate of major bleeding still means roughly 1 in 50 patients per year will experience a serious bleed. But for most people who need anticoagulation, the protection against stroke outweighs the bleeding risk, and Eliquis offers a better safety margin than warfarin on both counts.
Medications That Increase Bleeding Risk
Taking common pain relievers like ibuprofen or naproxen (NSAIDs) alongside Eliquis raises your bleeding risk. In the ARISTOTLE trial, patients who started an NSAID while on anticoagulation had a 61% higher rate of major bleeding and a 70% higher rate of clinically relevant bleeding compared to those who avoided NSAIDs. Naproxen specifically has been shown to increase Eliquis blood levels, which could amplify the anticoagulant effect. If you need occasional pain relief, acetaminophen (Tylenol) is generally a safer choice while on Eliquis.
Aspirin and other antiplatelet drugs also compound the bleeding risk when combined with Eliquis. Some people need both after a heart procedure, but that decision involves careful risk balancing. If you’re taking any over-the-counter pain medication regularly, it’s worth reviewing with your prescriber.
Dose Adjustments for Older or Smaller Adults
The standard dose of Eliquis is 5 mg twice daily. A lower dose of 2.5 mg twice daily is used for people who meet at least two of the following three criteria: age 80 or older, body weight of 132 pounds (60 kg) or less, or a serum creatinine level of 1.5 mg/dL or higher. These factors all affect how the drug is processed and cleared from the body, and the reduced dose helps keep blood levels in a safe range.
Getting the dose right matters in both directions. Taking too high a dose increases bleeding risk, while unnecessarily reducing the dose can leave you underprotected against clots. This is why doctors check your weight, age, and kidney markers before deciding which dose is appropriate.
Safety With Kidney Problems
Eliquis is often considered the preferred blood thinner for people with reduced kidney function because it relies less on the kidneys for clearance than some alternatives. The original clinical trials excluded patients with very poor kidney function (creatinine clearance below 25 mL/min), so there’s limited direct evidence for that group. However, the FDA label does allow Eliquis use in people with advanced kidney disease who aren’t on dialysis, with the standard or reduced dose depending on whether they meet the dose reduction criteria above.
If your kidney function falls in a borderline range, your doctor may monitor your labs more closely. For patients with creatinine clearance between 30 and 50 mL/min, adjustments to the timing of stopping the drug before surgery may also be needed.
Stopping Eliquis Before Surgery
One practical advantage of Eliquis over warfarin is how quickly it clears your system. For minor procedures, you typically stop it one day before (skipping two doses), which allows about two half-lives for the drug to wash out. For major surgery or procedures involving spinal anesthesia, stopping two days before (skipping four doses) gives four to five half-lives of clearance.
For dental extractions, root canals, cataract surgery, and minor skin procedures, it may be safe to continue Eliquis without interruption, similar to the approach used with warfarin. Your surgeon or dentist should coordinate with your prescriber on whether to pause the drug, since every missed dose is a window of reduced clot protection.
If your kidneys are moderately impaired (creatinine clearance between 30 and 50 mL/min), adding an extra day of interruption before the procedure is reasonable to allow more time for the drug to clear.
What Happens if You Have Serious Bleeding
One historical concern with newer blood thinners was the lack of a “reversal switch” in emergencies. That’s no longer the case. A reversal agent called andexanet alfa is approved specifically to reverse the anticoagulant effect of Eliquis (and rivaroxaban) in life-threatening or uncontrolled bleeding situations. It works by binding to the drug and neutralizing its effect on clotting. Hospitals that carry it are required to have protocols in place for when and how to use it, including monitoring criteria and guidelines for stopping treatment once bleeding is controlled.
This doesn’t eliminate all risk, but it does mean that emergency departments have a targeted tool for the worst-case scenario, something that wasn’t available when Eliquis first came to market.
Common Day-to-Day Side Effects
Beyond major bleeding events, the most commonly reported side effects of Eliquis are minor bleeding episodes: nosebleeds, bleeding gums, heavier menstrual periods, and easy bruising. These are expected consequences of any blood thinner and are usually manageable. Small cuts may take longer to stop bleeding than you’re used to, which is normal.
Some people also report nausea or general fatigue, though these are less common. If you notice blood in your urine or stool, unusually dark stool, or coughing up blood, those are signs of more significant bleeding that need prompt medical attention. Rashes or signs of an allergic reaction are rare but possible.